<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Edinburgh_OG_Downstream_Processing skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Edinburgh OG/Downstream Processing</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>PhagED: a molecular toolkit to re-sensitise ESKAPE pathogens</TITLE></P><DIV class="container"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV></DIV><NAV class="collapse navbar-collapse navbar-right" role="navigation"><DIV class="main-menu"><UL class="nav navbar-nav navbar-right"><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Project </A></LI><LI><A tabindex="-1" href="https://2018.igem.org/Team:Edinburgh_OG/project_background">Project Background</A></LI><LI class="dropdown-submenu"><A href="#" class="dropdown-toggle" data-toggle="dropdown-submenu">Project Design </A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/PHBV_Production">PHA Synthesis</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Downstream_Processing">Downstream Processing</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Scaling_Up">Scaling Up</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Model">Model</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Toggle_Switch">Glucose Toggle Switch</A></LI></UL><DIV><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/InterLab">InterLab Study</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Parts">Parts List</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Improve">Improve</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Demonstrate">Demonstrate</A></LI></DIV><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Practices </A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Human_Practices">Integrated Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Public_Engagement">Education and Public Engagement</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/life_cycle_assessment">Life Cycle Assessment</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Safety">Safety</A></LI></DIV><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Notebook </A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Notebook">Weekly Journal</A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Protocol">Protocol</A></LI></NAV></DIV><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Team">Team</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Acknowledgements </A></LI><LI><A href="https://2018.igem.org/Team:Edinburgh_OG/Attributions">Attributions</A></LI></DIV><LI class="medals"><A href="https://2018.igem.org/Team:Edinburgh_OG/Medals">Medal</A></LI></DIV></DIV><DIV><DIV><P> </P></DIV></DIV><DIV><DIV><P> </P></DIV></DIV><DIV><DIV><P> </P></DIV></DIV><DIV><DIV><P> </P></DIV></DIV><DIV><DIV><P> </P></DIV></DIV><H1 style="text-align: center;"><STRONG>Improvement on Downstream Processing</STRONG></H1><DIV class="column two_third_size"><P style="text-align: justify;">Another main limiting factor that the PHBV production is currently facing which hinders its commercialisation is the inefficient downstream processing which includes PHBV recovery from the microbial cells. PHBV is currently the only co-polymer commercially available; however, costs of production remain high and further research and development are tantamount to reaching economies of scale comparable to traditional plastics production in the industry. The high costs in manufacturing (ranging from £2 - £4 per kg) remain the limiting factor for widespread commercialization; prices closer to the £0.5 - £1.5 per kg range associated with traditional plastic production (e.g. polyethylene, polyvinylchloride, etc.) would ensure price-competitiveness of the bioplastic in the market (Choi and Lee, 1999).
This point is supported by our <A href="https://2018.igem.org/Team:Edinburgh_OG/life_cycle_assessment">Life Cycle Assessment</A> as well as our discussion with <A href="https://2018.igem.org/Team:Edinburgh_OG/Human_Practices">Cambridge Consultants</A>. To address this issue, we propose an in-situ secretion system by the <EM>E. coli</EM>  which potentially will be more environmentally friendly and time-efficient.</P><H2>The phasin and hemolysin secretion system (hemolysin BD and hemolysin A)</H2><H3><STRONG>Overview</STRONG></H3><P style="text-align: justify;">This study describes the construction and characterisation of several new BioBricks, which will allow the future investigation of PHB secretion by the Hemolysin transporter (HlyBD). The findings of present study suggest that overexpression of the HlyBD transporter affects the bacterial growth of recombinant <EM>E. coli</EM> strain transformed with T7 promoter-HlyBD plasmid. Surprisingly, with the recombinant <EM>E. coli</EM>  strains co-transformed the two plasmids for PHB production and PHB secretion systems, overexpression of the HlyBD transporter with 0.1mM and 0.4mM IPTG were shown to promote the bacterial growth.</P><H3><STRONG>Background</STRONG></H3><P style="text-align: justify;">Type I secretion system is one of common systems for protein secretion and have been engineered previously for bioproduction (Green and Mecsas, 2016). This secretion pathway is found native uropathogenic <EM>E. coli</EM> strain and capable to secrete recombinant protein fused with HlyA single peptide on its C terminal. HlyB and HlyD are essential component of hemolysin secretion system which located in the inner membrane, being an ATP binding cassette and a membrane fused protein respectively (Fath and Kolter, 1993).</P><H3><STRONG>Aim</STRONG></H3><P style="text-align: justify;">We aim to improve microbial PHB production by introducing a synthetic microorganisms with an inducible hemolysin secretion system. We investigated the effect of the new developed Biobricks to the recombinant <EM>E. coli</EM> strains and the effect of <EM>hlyBD</EM>  expression to PHB production through the Nile red fluorescence method. The plasmids constructed will facilitate the further study of the HlyBD transporter and its impact on PHB secretion.</P><H3><STRONG>Materials and Methods</STRONG></H3><P style="text-align: justify;">Biobricks BBa_ BBa_K1166002 and BBa_K 1149051 were used in the project providing <EM>phaP</EM>, <EM>hlyA</EM>,<EM> hlyB</EM>  and <EM>hlyD</EM>  components to establish new construct of pSB3T5-T7-HlyDB-PhaP-HlyA. This construct was co-transformed with <EM>phaCAB</EM>  operon and cultured in M9 medium with 3% glucose at 37℃  shaker. During the culture, different concentrations of induction material (IPTG) was added for overexpression of <EM>hlyBD</EM>. And optical density was measured to investigate the effect on cell growth. Fluorescence intensity measured by plate reader represented the production of PHB.</P><H3><STRONG>Results and Discussion</STRONG></H3><P style="text-align: justify;">Despite the expression of <EM>hlyBD</EM>  exert a negative effect to the bacterial growth of <EM>E. coli</EM> with T7 promoter-hlyBD, it was demonstrated to facilitate the growth of <EM>E. coli</EM> strain with pSB3T5-T7-HlyDB-PhaP-HlyA and <EM>phaCAB</EM>  operon. The effect of new Biobricks expression to recombinant <EM>E. coli</EM>  would provide essential information for future analysis. Furthermore, the fluorescent signal of Nile red to PHB production generated in the present study provides preliminary data supporting the concept of <EM>hlyBD</EM>  expression in PHB secretion which then promote PHB production.</P><P style="text-align: center;"><STRONG>Figure 1 </STRONG>The growth study of <EM>E. coli</EM>  Bl21(DE3) strain that harboured pSB3T5-T7-<EM>hlyDB</EM>-<EM>phaP</EM>-<EM>hlyA</EM> and <EM>phaCAB</EM> operon – The strains were cultured with or with IPTG and the results are represented as the mean OD600nm ± S.E.M.</P><P style="text-align: center;"><STRONG>Figure 2 </STRONG>Fluorescence intensity detection of <EM>E. coli</EM>  BL21(DE3) strain that harboured pSB3T5-T7<EM>hlyDB</EM>-<EM>phaP</EM>-<EM>hlyA</EM> and <EM>phaCAB</EM>  operon under Nile red stain (performed in triplicate) – Results are represented as the mean fluorescent strength ± S.E.M. measured at 520 nm excitation and 590 nm emission wavelengths in 24 and 48 hours</P><P> </P><H3><STRONG>References</STRONG></H3><UL><LI>Choi, J. and Lee, S. 1999. Efficient and economical recovery of poly(3-hydroxybutyrate) from recombinant Escherichia coli by simple digestion with chemicals. <EM> Biotechnology and Bioengineering</EM>, 62(5), pp.546-553.
</LI><LI>Green, E.R. and Mecsas, J., 2016. Bacterial secretion systems–an overview. <EM>Microbiology spectrum</EM>, 4(1).</LI><LI>Fath, M.J. and Kolter, R., 1993. ABC transporters: bacterial exporters. <EM>Microbiological reviews</EM>, <EM>57</EM>(4), pp.995-1017.</LI></UL></DIV></DIV></BODY></HTML>